Kuros Biosciences Ag
(OTC) CSBTF
Kuros Biosciences Ag Financials at a Glance
Market Cap
$1.11B
Revenue (TTM)
$205.11M
Net Income (TTM)
$2.08M
EPS (TTM)
$0.06
P/E Ratio
442.37
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$27.85
Volume
1,370
Open
$27.85
Price
$27.85
Volume
1,370
Open
$27.85
Previous Close
$27.85
Daily Range
$27.85 - $27.85
52-Week Range
$19.44 - $42.81
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$27.85
Volume
1,370
Open
$27.85
Previous Close
$27.85
Daily Range
$27.85 - $27.85
52-Week Range
$19.44 - $42.81
CSBTF News
CSBTF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kuros Biosciences Ag
Industry
Biotechnology
Sector
Health CareEmployees
178
CEO
Christopher T. Fair
Website
kurosbio.comHeadquarters
Schlieren, 8952, CH
CSBTF Financials
Key Financial Metrics (TTM)
Gross Margin
87%
Operating Margin
6%
Net Income Margin
1%
Return on Equity
3%
Return on Capital
11%
Return on Assets
2%
Earnings Yield
0.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.11B
Shares Outstanding
39.18M
Volume
1.37K
Short Interest
0.00%
Avg. Volume
133.508
Financials (TTM)
Gross Profit
$104.84M
Operating Income
$7.33M
EBITDA
$10.13M
Operating Cash Flow
$378.05K
Capital Expenditure
$2.03M
Free Cash Flow
$2.40M
Cash & ST Invst.
$15.67M
Total Debt
$3.94M
Kuros Biosciences Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$66.07M
+219.2%
Gross Profit
$56.40M
+223.7%
Gross Margin
85.36%
N/A
Market Cap
$1.11B
N/A
Market Cap/Employee
$9.12M
N/A
Employees
122
N/A
Net Income
$3.65M
+142.1%
EBITDA
$5.72M
+285.0%
Quarterly Fundamentals
Net Cash
$11.73M
-2.8%
Accounts Receivable
$31.86M
+397.0%
Inventory
$16.93M
+248.6%
Long Term Debt
$3.42M
+118.6%
Short Term Debt
$517.59K
-10.5%
Return on Assets
1.53%
N/A
Return on Invested Capital
10.51%
N/A
Free Cash Flow
$914.82K
+139.2%
Operating Cash Flow
$1.95M
+192.7%